+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 146 Pages
  • October 2022
  • Region: Global
  • IMARC Group
  • ID: 5682559

Quick Summary:

In today's medical world, companion diagnostics stand as integral contributors to efficient and secure healthcare delivery. They enhance understanding of disease biology and the mechanism of action (MOA), assist medical professionals in pinpointing potential side effects or risks of therapeutic products, and are pivotal in accelerating targeted, tailored treatments in oncology and beyond.

Against the backdrop of increasing cancer prevalence, heightened demand for in-vitro diagnostics and targeted therapies, and the rise of personalized and precision medicine, the global companion diagnostics market is primed for growth. The surging demand for next-generation sequencing (NGS), increasing clinical trials, and focus on co-developing diagnostic technologies and drugs lay a solid foundation for market expansion. The emergence of new biomarkers, growing approvals of companion diagnostics, and rising inter-company collaborations for developing innovative companion diagnostic products also bode well for the market's forward trajectory.

The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 11.7 Billion by 2027, exhibiting a CAGR of 15.22% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Companion diagnostics refer to a combination of tests and therapies that provide essential information about corresponding therapeutic products to deliver safe and effective medical care. These diagnostics also offer an in-depth understanding of disease biology and the mechanism of action (MOA), which help healthcare professionals determine the potential side effects or risks of a therapeutic product on the patient. At present, companion diagnostics are extensively utilized in oncology to deliver targeted therapies and personalized medicines to patients.

The growing prevalence of cancer, in confluence with the escalating demand for in-vitro diagnostics and targeted therapies, represents one of the key factors impelling the global companion diagnostics market growth. Apart from this, personalized healthcare (PHC) and precision medicine are also gaining traction in the treatment of cardiovascular, neurological, infectious and inflammatory diseases, which, in turn, is bolstering the growth of the market. Furthermore, the escalating demand for next-generation sequencing (NGS), the rising number of clinical trials and the increasing focus on the co-development of drugs and diagnostic technologies are contributing to the market growth. The introduction of new biomarkers, rising approvals of companion diagnostics and increasing collaboration between companies to develop novel companion diagnostic products are some of the other factors positively influencing the market growth. Currently, due to the spread of the coronavirus disease (COVID-19), diagnostic service providers are providing test services to healthcare providers. They are also utilizing companion diagnostics to detect the efficacy of COVID-19 drugs among patients undergoing oncology therapies.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product & service, technology, indication and end user.

Breakup by Product & Service:

  • Assays, Kits and Reagents
  • Software and Services

Breakup by Technology:

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Real-time PCR (RT-PCR)
  • Gene Sequencing
  • Others

Breakup by Indication:

  • Cancer
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others
  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Breakup by End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

1. What was the size of the global companion diagnostics market in 2021?
2. What is the expected growth rate of the global companion diagnostics market during 2022-2027?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?
Frequently Asked Questions about the Global Companion Diagnostics Market

What is the estimated value of the Global Companion Diagnostics Market?

The Global Companion Diagnostics Market was estimated to be valued at $5 Billion in 2021.

What is the growth rate of the Global Companion Diagnostics Market?

The growth rate of the Global Companion Diagnostics Market is 15.2%, with an estimated value of $11.7 Billion by 2027.

What is the forecasted size of the Global Companion Diagnostics Market?

The Global Companion Diagnostics Market is estimated to be worth $11.7 Billion by 2027.

Who are the key companies in the Global Companion Diagnostics Market?

Key companies in the Global Companion Diagnostics Market include Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Companion Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product & Service
6.1 Assays, Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Immunohistochemistry (IHC)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Gene Sequencing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Indication
8.1 Cancer
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Lung Cancer
8.1.2.2 Breast Cancer
8.1.2.3 Colorectal Cancer
8.1.2.4 Gastric Cancer
8.1.2.5 Melanoma
8.1.2.6 Others
8.1.3 Market Forecast
8.2 Neurological Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical & Biopharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BioMerieux
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Roche Holding AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Myriad Genetics Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Siemens Healthcare
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Thermo Fisher Scientific Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
List of Figures
Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2021
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2021
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2021
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2021
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2021
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 92: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 93: Global: Companion Diagnostics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2022-2027
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux
  • Danaher Corporation
  • Roche Holding AG
  • Myriad Genetics Inc.
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...